Exploring the Temporal Relation between Body Mass Index and Corticosteroid Metabolite Excretion in Childhood

Britt J Van Keulen1, Conor V Dolan2, Ruth Andrew3

  • 1Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Endocrinology, Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Nutrients
|May 28, 2020
PubMed

Insights

Childhood body mass index (BMI) predicts changes in hypothalamus-pituitary-adrenal (HPA) axis activity, suggesting HPA axis alterations are a consequence, not a cause, of obesity. This finding impacts understanding of childhood obesity development.

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Pediatric Health

Background:

  • Childhood obesity is linked to altered hypothalamus-pituitary-adrenal (HPA) axis activity.
  • The causal relationship between HPA axis function and obesity in children remains unclear.
  • Understanding this temporal relationship is crucial for effective obesity interventions.

Purpose of the Study:

  • To investigate the temporal relationship between body mass index (BMI) and cortisol production/metabolism in children.
  • To determine if BMI predicts HPA axis activity or vice versa.
  • To clarify whether HPA axis alterations are a cause or consequence of childhood obesity.

Main Methods:

  • Prospective follow-up study of 218 children assessed at ages 9, 12, and 17 years.
  • Analysis of morning urine samples for cortisol metabolites using gas chromatography-tandem mass spectrometry.
  • Application of cross-lagged regression models to assess bidirectional relationships between BMI and HPA axis parameters.

Main Results:

  • Childhood BMI positively predicted later cortisol metabolite excretion (p=0.03).
  • BMI also predicted the balance of 11β-hydroxysteroid dehydrogenase (HSD) activities (p=0.07).
  • Cytochrome P450 3A4 activity predicted later BMI (p=0.01), while HPA axis activity did not predict BMI.

Conclusions:

  • Changes in BMI across the normal range predict alterations in HPA axis activity in children.
  • HPA axis alterations observed in childhood obesity are likely a consequence, not a cause, of increased BMI.
  • This research reframes the understanding of the interplay between metabolic status and endocrine function in pediatric obesity.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
126
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.0K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K